Uffe Schou Loeve

Uffe Schou Loeve

Auto-generated profile, based on publicly available information

Uffe Schou Loeve

Department of Surgery, Aarhus University Hospital, Aarhus, Denmark

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
THTenna Vesterman Henriksen
Tenna Vesterman Henriksen
NTNoelia Tarazona
Noelia Tarazona
AFAmanda Frydendahl
Amanda Frydendahl
TRThomas Reinert
Thomas Reinert
FGFrancisco Gimeno-Valiente
Francisco Gimeno-Valiente
CAClaus Lindbjerg Andersen
Claus Lindbjerg Andersen
Purpose: Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early relapse detection may have a major impact on treatment decisions and patient management for stage III colorectal cancer patients. Beyond assessing the predictive power of postoperative ctDNA detection, we explored the added benefits of serial analysis: assessing adjuvant chemotherapy (ACT) efficacy, early relapse detection, and ctDNA growth rates. Experimental Design: We recruited 168 patients with stage III colorectal cancer treated with curative intent at Danish and Spanish hospitals between 2014 and 2019. To quantify ctDNA in plasma samples (n = 1,204), 16 patient-specific somatic single-nucleotide variants were profiled using multiplex-PCR, next-generation sequencing. Results: Detection of ctDNA was a strong recurrence predictor postoperatively [HR = 7.0; 95% confidence interval (CI), 3.7–13.5; P < 0.001] and directly after ACT (HR = 50.76; 95% CI, 15.4–167; P < 0.001). The recurrence rate of postoperative ctDNA-positive patients treated with ACT was 80% (16/20). Only patients who cleared ctDNA permanently during ACT did not relapse. Serial ctDNA assessment after the end of treatment was similarly predictive of recurrence (HR = 50.80; 95% CI, 14.9–172; P < 0.001), and revealed two distinct rates of exponential ctDNA growth, slow (25% ctDNA-increase/month) and fast (143% ctDNA-increase/month; P < 0.001). The ctDNA growth rate was prognostic of survival (HR = 2.7; 95% CI, 1.1–6.7; P = 0.039). Serial ctDNA analysis every 3 months detected recurrence with a median lead-time of 9.8 months compared with standard-of-care computed tomography. Conclusions: Serial postoperative ctDNA analysis has a strong prognostic value and enables tumor growth rate assessment. The novel combination of ctDNA detection and growth rate assessment provides unique opportunities for guiding decision-making. See related commentary by Morris and George, p. 438


29 November 2008 in European Journal of Heart Failure
Verified
Journal Article
Closed access
AAAsger Andersen
Asger Andersen
JNJan Møller Nielsen
Jan Møller Nielsen
CPChristian Daugaard Peters
Christian Daugaard Peters
USUffe Kjær Schou
Uffe Kjær Schou
ESErik Sloth
Erik Sloth
JNJens Erik Nielsen-Kudsk
Jens Erik Nielsen-Kudsk
Background: Sustained pressure overload of the right ventricle (RV) causes RV hypertrophy and failure. Cyclic-GMP has previously been shown to modulate left ventricular hypertrophy. Aim: To evaluate the effects of sildenafil, a phosphodiesterase-5 (PDE5) inhibitor elevating c-GMP, on myocardial hypertrophy and function in rats with RV hypertrophy. Methods: Rats were pulmonary trunk banded (PTB) and randomized to receive sildenafil (SIL) or vehicle (VEC) for three (n = 14) and nine weeks (n = 18). In addition, rats with established RV hypertrophy were randomized to SIL or VEC (n = 17) three weeks after PTB. Right ventricular function was evaluated by echocardiography and RV hypertrophy by histology and RV weight. Results: Sildenafil failed to inhibit the development of RV hypertrophy when given for both 3 and 9 weeks. On the contrary, sildenafil increased RV hypertrophy after 3 weeks (RV/bodyweight: SIL 0.099±0.016 vs. VEC 0.081±0.011; p<0.05) and total heart weight after 9 weeks (SIL 1.05±0.10 vs. VEC 0.93±0.08g; p<0.05). Sildenafil also failed to reverse established RV hypertrophy, but significantly improved RV myocardial function as measured by Tricuspid Annular Plane Systolic Excursion (TAPSE: SIL 1.8±0.027 vs. VEC 1.39±0.037 mm; p<0.05). Conclusion: PDE5 inhibition by sildenafil failed to prevent or reverse RV hypertrophy in rats operated by pulmonary trunk banding. It actually increased RV hypertrophy and improved RV contractile function when given to rats with established RV hypertrophy.

1 November 2005 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
SKSoo Wan Kim
Soo Wan Kim
USUffe K. Schou
Uffe K. Schou
CPChristian Daugaard Peters
Christian Daugaard Peters
SSSophie de Seigneux
Sophie de Seigneux
TKTae-Hwan Kwon
Tae-Hwan Kwon
SNSøren Nielsen
Søren Nielsen
It was hypothesized that dysregulation of renal epithelial sodium channel (ENaC) subunits and/or 11β-hydroxysteroid dehydrogenase (11βHSD2) may play a role in the increased sodium retention in liver cirrhosis (LC). Experimental LC was induced in rats by CCl4 (1 ml/kg, intraperitoneally, twice a week) for 12 wk (protocol 1) or for 11 wk (protocol 2). In both protocols, one group of rats with cirrhosis showed significantly decreased urinary sodium excretion and urinary Na/K ratio (group A), whereas a second group exhibited normal urinary sodium excretion (group B) compared with controls, even though extensive ascites was seen in both groups of rats with cirrhosis. In group A, protein abundance of α-ENaC was unchanged, whereas β-ENaC abundance was decreased in the cortex/outer stripe of outer medulla compared with controls. The γ-ENaC underwent a complex change associated with increased abundance of the 70-kD band with a concomitant decrease in the main 85-kD band, corresponding to an aldosterone effect. In contrast, no changes in the abundance of ENaC subunit were observed in group B. Immunoperoxidase microscopy revealed an increased apical targeting of α-, β-, and γ-ENaC subunits in distal convoluted tubule (DCT2), connecting tubule (CNT), and cortical and medullary collecting duct segments in group A but not in group B. Immunolabeling intensity of 11βHSD2 in the DCT2, CNT, and cortical collecting duct was significantly reduced in group A but not in group B, and this was confirmed by immunoblotting. In conclusion, increased apical targeting of ENaC subunits combined with diminished abundance of 11βHSD2 in the DCT2, CNT, and cortical collecting duct is likely to play a role in the sodium retaining stage of liver cirrhosis.

1 April 2018 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
EPEmmeline G Peters
Emmeline G Peters
BSBoudewijn J J Smeets
Boudewijn J J Smeets
JNJesper Nors
Jesper Nors
CBChristian M Back
Christian M Back
JFJonas A Funder
Jonas A Funder
Misha LuyerMisha Luyer
Misha Luyer

5 January 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJonas D. Baandrup
Jonas D. Baandrup
LMLars H. Markvardsen
Lars H. Markvardsen
CPChristian Daugaard Peters
Christian Daugaard Peters
USUffe K. Schou
Uffe K. Schou
JJJens L. Jensen
Jens L. Jensen
USUlf Simonsen
Ulf Simonsen
The present study investigated whether changes in gene expression in the right ventricle following pulmonary hypertension can be attributed to hypoxia or pressure loading. To distinguish hypoxia from pressure-induced alterations, a group of rats underwent banding of the pulmonary trunk (PTB), sham operation, or the rats were exposed to normoxia or chronic, hypobaric hypoxia. Pressure measurements were performed and the right ventricle was analyzed by Affymetrix GeneChip, and selected genes were confirmed by quantitative PCR and immunoblotting. Right ventricular systolic blood pressure and right ventricle to body weight ratio were elevated in the PTB and the hypoxic rats. Expression of the same 172 genes was altered in the chronic hypoxic and PTB rats. Thus, gene expression of enzymes participating in fatty acid oxidation and the glycerol channel were downregulated. mRNA expression of aquaporin 7 was downregulated, but this was not the case for the protein expression. In contrast, monoamine oxidase A and tissue transglutaminase were upregulated both at gene and protein levels. 11 genes (e.g. insulin-like growth factor binding protein) were upregulated in the PTB experiment and downregulated in the hypoxic experiment, and 3 genes (e.g. c-kit tyrosine kinase) were downregulated in the PTB and upregulated in the hypoxic experiment. Pressure load of the right ventricle induces a marked shift in the gene expression, which in case of the metabolic genes appears compensated at the protein level, while both expression of genes and proteins of importance for myocardial function and remodelling are altered by the increased pressure load of the right ventricle. These findings imply that treatment of pulmonary hypertension should also aim at reducing right ventricular pressure.